|
Real-time Estimate
Cboe BZX
23:40:40 23/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.555 USD | -7.43% |
|
-4.66% | +56.75% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID THERAPEUTICS INC. | Bio Therapeutic Drugs | -7.43% | -4.66% | +56.75% | +102.78% | -25.94% | 539M |  | |  |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
